Internal Medicine, Endocrinology, Diabetes, & Metabolism · Beverly Hills, CA
NPI
1225064884
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8816 Burton Way
Beverly Hills, CA, 90211
Phone (310) 657-3030
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
5,204 services
Medicare patients, 2024
207
Average age 75
Drug cost, 2024
$1.4M
2,824 prescriptions
Company payments, 2025
$1,760
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pejman Cohan was code 99215 (office e&m - established), 665 times for 197 patients. In total Pejman Cohan billed 5,204 services in 53 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 665 | 197 | $137.24 | $91K |
| 36415 Venipuncture Blood Collection | Office | 233 | 104 | $8.58 | $1,998 |
| 83036 Blood Count | Office | 201 | 89 | $9.52 | $1,914 |
| 96372 Injection Administration | Office | 179 | 35 | $10.72 | $1,919 |
| 84443 Clinical Chemistry | Office | 164 | 73 | $16.46 | $2,699 |
| 84439 Clinical Chemistry | Office | 163 | 73 | $8.84 | $1,441 |
| 80069 Clinical Chemistry | Office | 160 | 72 | $8.51 | $1,362 |
| 84481 Clinical Chemistry | Office | 158 | 73 | $16.60 | $2,623 |
| 80076 Clinical Chemistry | Office | 153 | 69 | $8.01 | $1,226 |
| 85025 Blood Count | Office | 152 | 70 | $7.61 | $1,157 |
| 83735 Clinical Chemistry | Office | 148 | 70 | $6.57 | $972 |
| 80061 Clinical Chemistry | Office | 148 | 68 | $13.12 | $1,942 |
| 83550 Clinical Chemistry | Office | 147 | 69 | $8.57 | $1,260 |
| 82728 Clinical Chemistry | Office | 147 | 69 | $13.36 | $1,964 |
| 83540 Clinical Chemistry | Office | 147 | 69 | $6.34 | $932 |
By year: 2022 $140K for 4,741 services; 2023 $136K for 4,483 services; 2024 $156K for 5,204 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 233 | 104 | $8.58 | $1,998 |
| 83036 Blood Count | 201 | 89 | $9.52 | $1,914 |
| 84443 Clinical Chemistry | 164 | 73 | $16.46 | $2,699 |
| 84439 Clinical Chemistry | 163 | 73 | $8.84 | $1,441 |
| 80069 Clinical Chemistry | 160 | 72 | $8.51 | $1,362 |
| 84481 Clinical Chemistry | 158 | 73 | $16.60 | $2,623 |
| 80076 Clinical Chemistry | 153 | 69 | $8.01 | $1,226 |
| 85025 Blood Count | 152 | 70 | $7.61 | $1,157 |
| 83735 Clinical Chemistry | 148 | 70 | $6.57 | $972 |
| 80061 Clinical Chemistry | 148 | 68 | $13.12 | $1,942 |
Medicare prescription drug claims, 2024
In 2024, the drug Pejman Cohan prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 351 prescriptions and refills. In total Pejman Cohan wrote 2,824 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 351 | 693 | 73 | $30K |
| Mounjaro Tirzepatide | 258 | 316 | 34 | $326K |
| Ozempic Semaglutide | 99 | 153 | 20 | $146K |
| Liothyronine Sodium Generic | 84 | 173 | 19 | $2,719 |
| Jardiance Empagliflozin | 65 | 127 | 11 | $73K |
| Metformin Hcl Generic | 63 | 121 | 15 | $570 |
| Farxiga Dapagliflozin Propanediol | 62 | 108 | Under 11 | $60K |
| Metformin Hcl Er Metformin Hcl | 59 | 161 | 20 | $1,496 |
| Rosuvastatin Calcium Generic | 59 | 173 | 25 | $1,281 |
| Xyosted Testosterone Enanthate | 52 | 93 | 11 | $59K |
| Glimepiride Generic | 45 | 97 | 12 | $271 |
| Levothyroxine Sodium Generic | 43 | 91 | 11 | $411 |
| Amlodipine Besylate Generic | 36 | 102 | Under 11 | $533 |
| Tresiba Flextouch U-200 Insulin Degludec | 34 | 58 | Under 11 | $38K |
| Genotropin Somatropin | 34 | 55 | Under 11 | $124K |
Brand drugs: 1,547 claims; generic drugs: 1,225 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pejman Cohan $1,760 ($1,760 in general payments such as food, travel and fees) from 25 companies. The largest payer was Amgen Inc. with $232.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 11 | $232 |
| Novo Nordisk Inc NVO | 8 | $197 |
| Recordati_rare_diseases_inc. | 4 | $146 |
| Radius Health, Inc. | 4 | $122 |
| Lilly USA, LLC LLY | 5 | $111 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $103 |
| Abbott Laboratories ABT | 3 | $81.48 |
| Mannkind Corporation MNKD | 3 | $80.92 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $77.99 |
| Tolmar, Inc. | 5 | $77.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.